1613148-32-5

Basic information

• Product Name: 3-(1-(2,5-dichlorophenyl)ethoxy)-2-nitropyridine
• Synonyms: 3-(1-(2,5-dichlorophenyl)ethoxy)-2-nitropyridine
• CAS NO: 1613148-32-5
• Molecular Weight: 313.14
• Mol File: 1613148-32-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-(1-(2,5-dichlorophenyl)ethoxy)-2-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(1-(2,5-dichlorophenyl)ethoxy)-2-nitropyridine(1613148-32-5)
• EPA Substance Registry System: 3-(1-(2,5-dichlorophenyl)ethoxy)-2-nitropyridine(1613148-32-5)

Safety Data

• Hazardous Substances Data: 1613148-32-5(Hazardous Substances Data)

Upstream product

• 54231-35-5 3-fuoro-2-nitropyridine 
• 1475-12-3 1-(2,5-dichlorophenyl)ethanol 

Downstream Products

• 1613148-33-6 3-(1-(2,5-dichlorophenyl)ethoxy)pyridin-2-amine 
• 1613148-34-7 5-bromo-N,N-bis(tert-butoxycarbonyl)-3-(1-(2,5-dichlorophenyl)ethoxy)pyridin-2-amine 
• 1613148-35-8 N,N-bis(tert-butoxycarbonyl)-3-(1-(2,5-dichlorophenyl)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine 
• 1613148-36-9 3-(6-(bis(tert-butoxycarbonyl)amino)-5-(1-(2,5-dichlorophenyl)ethoxy)pyridin-3-yl)-6-(tert-butoxycarbonyl)-5,6,7,8-tetrahydro-1,6-naphthyridin-8-ol 
• 1613148-38-1 N, N-bis(tert-butoxycarbonyl)-3-(1-(2,5-dichlorophenyl)ethoxy)-5-(6-trityl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-3-yl)pyridin-2-amine 
• 1613148-31-4 3-(6-amino-5-(1-(2,5-dichlorophenyl)ethoxy)pyridin-3-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-8-ol 

Relevant articles and documents

Substituted ring compound and its method and use thereof

The invention provides a substituted cyclic compound as well as a use method and application thereof. The compound is a compound as shown in a formula (I) or stereoisomers, stereomers, tautomers, nitric oxides, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as shown in the formula (I). The invention further provides a medicament composition containing the compound. The compound and the medicament composition are capable of regulating the activity of protein kinase in a biological sample body and are used for protecting, treating or relieving proliferative diseases of patients. The formula (I) is as shown in the specification.